Wells Fargo & Company Lisata Therapeutics, Inc. Comm Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

A detailed history of Wells Fargo & Company transactions in Lisata Therapeutics, Inc. Comm stock. As of the latest transaction made, Wells Fargo & Company holds 1 shares of LSTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-53 Reduced 98.15%
1 $0
Q1 2024

May 10, 2024
BUY
N/A
1 Added 1.89%
54 $0
Q4 2023

Feb 09, 2024
BUY
N/A
4 Added 8.16%
53 $0
Q3 2023

Nov 13, 2023
BUY
N/A
18 Added 58.06%
49 $0
Q2 2023

Aug 15, 2023
BUY
N/A
2 Added 6.9%
31 $0
Q4 2022

Feb 13, 2023
BUY
N/A
1 Added 3.57%
29 $0
Q3 2022

Nov 14, 2022
BUY
N/A
28 New
28 $0

Others Institutions Holding LSTA

# of Institutions
24
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About LISATA THERAPEUTICS, INC. COMM

LSTA Quotes by TradingView
  • Ticker LSTA
More about LSTA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email